HIV 1 News and Research

RSS

Exploring flavonols in the inhibition of SARS-CoV-2 replication

Researchers assessed the efficiency of flavonols in SARS-CoV-2 inhibition.

4 Jul 2022

The importance of smallpox vaccination as a preventive measure in controlling recent outbreaks of monkeypox

Scientists have described the importance of smallpox vaccination as a preventive measure in controlling recent outbreaks of monkeypox infection.

4 Jul 2022

The role of vitamin D in H1N1 influenza and SARS-CoV-2 infection

A new study focused on determining Vitamin D's role in SARS-CoV-2 and H1N1 influenza. In this study, researchers determined the effect of vitamin D supplements on the lung anti-viral response in animal models.

4 Jul 2022

Nomogram helps predict anal cancer risk in HIV patients

Both cervical and anal cancer are caused by human papillomavirus. Both diseases also share a common precursor: abnormal cells known as high-grade squamous intraepithelial lesions (HSIL).

1 Jul 2022

HIV accelerates epigenetic aging soon after initial HIV infection

HIV has an "early and substantial" impact on aging in infected people, accelerating biological changes in the body associated with normal aging within just two to three years of infection, according to a study by UCLA researchers and colleagues.

1 Jul 2022

Crystal structure of a human endogenous reverse transcriptase revealed

The crystal structure of a human endogenous reverse transcriptase has similarities to HIV reverse transcriptase, a well-known tractable drug target, which will help design drugs to treat cancer and other diseases, according to a study co-authored by a Rutgers researcher.

30 Jun 2022

East African newborns nearly five times more likely to have neural tube defects

Newborns, whose brains, spines or spinal cords do not properly develop in utero, can be born with neural tube defects (NTD), increasing their risk of physical disabilities, intellectual impairments and death.

30 Jun 2022

Anticancer drug candidate that targets a human protein could be a pan-viral medication

More than two years into the COVID-19 pandemic, people are realizing that the "new normal" will probably involve learning to co-exist with SARS-CoV-2. Some treatments are available, but with new variants emerging, researchers are looking toward new strategies.

29 Jun 2022

Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants

In a recent study posted to the bioRxiv* pre-print server, researchers in the United States described a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibody (mAb) SP1-77 that broadly neutralized its multiple variants of concern (VOCs).

28 Jun 2022

Should monkeypox be considered a sexual transmitted infection?

The present monkeypox outbreak is marked by sustainable human-to-human transmission.

28 Jun 2022

CDC data shows a sharp decrease in HIV testing during first year of COVID-19 pandemic

New CDC data published ahead of National HIV Testing Day (Monday, June 27) show a sharp decrease in the number of CDC-funded HIV tests administered in health care and non-health-care settings (43% and 50%, respectively) from 2019 to 2020, the first year of the COVID-19 pandemic.

28 Jun 2022

SARS-CoV-2 virus undertakes a massive takeover of the body's fat-processing system

The virus that causes COVID-19 undertakes a massive takeover of the body's fat-processing system, creating cellular storehouses of fat that empower the virus to hijack the body's molecular machinery and cause disease.

28 Jun 2022

Antiretroviral drug used to treat HIV ameliorates cognitive deficits in mouse model of Down syndrome

Lamivudine, a commonly-used antiretroviral drug for treating HIV, improves cognition in a mouse model of Down syndrome, according to the findings of a joint new study by researchers at the Centre for Genomic Regulation (CRG) and the IrsiCaixa AIDS Research Institute, a center jointly promoted by the "la Caixa" Foundation and the Department of Health of the Generalitat de Catalunya.

28 Jun 2022

Researchers identify an epigenetic signature associated to the development of MIS-C after COVID-19

Researchers from the Cancer Epigenetics group led by Dr. Manel Esteller at the Josep Carreras Leukaemia Research Institute and Dr. Aurora Pujol, from the Bellvitge Biomedical Research Institute, have identified an epigenetic signature associated to the development of the Multisystem Inflammatory Syndrome in Children (MIS-C) after a SARS-CoV-2 virus infection.

27 Jun 2022

HIV 1 News and Research

Exploring flavonols in the inhibition of SARS-CoV-2 replication

The importance of smallpox vaccination as a preventive measure in controlling recent outbreaks of monkeypox

The role of vitamin D in H1N1 influenza and SARS-CoV-2 infection

Nomogram helps predict anal cancer risk in HIV patients

HIV accelerates epigenetic aging soon after initial HIV infection

Crystal structure of a human endogenous reverse transcriptase revealed

East African newborns nearly five times more likely to have neural tube defects

Anticancer drug candidate that targets a human protein could be a pan-viral medication

Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants

Should monkeypox be considered a sexual transmitted infection?

CDC data shows a sharp decrease in HIV testing during first year of COVID-19 pandemic

SARS-CoV-2 virus undertakes a massive takeover of the body's fat-processing system

Antiretroviral drug used to treat HIV ameliorates cognitive deficits in mouse model of Down syndrome

Researchers identify an epigenetic signature associated to the development of MIS-C after COVID-19

Chemically modified rocaglates have a stronger effect against viral replication

Review and case study illustrates the challenges of monkeypox

CDC continues investigation of meningococcal disease outbreak among gay and bisexual men in Florida

Scientists develop suitable human cell line for anti-SARS-CoV-2 drug screening

Natural and hybrid immunity dynamics in South African mothers

Listeria-based booster vaccine strategy offers improved protection against recurrent colorectal cancer

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News